Sonendo, Inc.

Equities

SONX

US8354311073

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:57:57 2024-04-26 pm EDT			5-day change	1st Jan Change
0.096 ^USD	+5.24%		+4.46%	-54.29%

Apr. 10	Sonendo, Inc. Announces Sadie Stern Not to Stand for Reelection to the Board of Directors	CI
Mar. 13	North American Morning Briefing : Stock Futures -2-	DJ

Sonendo, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024

March 11, 2024 at 04:05 pm EDT

Sonendo, Inc. provided revenue guidance for the first quarter and full year of 2024. First quarter revenue is expected to be approximately $6 million.

The Company expects the full year 2024 total revenue to be in the range of $28.0 million to $30.0 million, which excludes all revenues from the TDO software segment.

Latest news about Sonendo, Inc.

Sonendo, Inc. Announces Sadie Stern Not to Stand for Reelection to the Board of Directors	Apr. 10	CI
North American Morning Briefing : Stock Futures -2-	Mar. 13	DJ
Transcript : Sonendo, Inc., Q4 2023 Earnings Call, Mar 11, 2024	Mar. 11
Sonendo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 11	CI
Sonendo, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024	Mar. 11	CI
Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023	Mar. 11	CI
Sonendo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 11	CI
Sonendo, Inc. Announces CFO Changes	Mar. 08	CI
Sonendo, Inc. to Amend its Amended and Restated Credit Agreement and Guaranty with Perceptive Credit Holdings, LP	Mar. 04	CI
Valsoft Corporation Inc. acquired TDO Software from Sonendo, Inc. for approximately $16 million.	Mar. 03	CI
Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024	Feb. 14	CI
Sonendo, Inc. Partners with Best for Dentistry to Continue Expanding Access to the Innovative GentleWave Procedure	Jan. 03	CI
Sonendo, Inc.(OTCPK:SONX) dropped from S&P TMI Index	Nov. 28	CI
Sonendo, Inc. Primary Exchange Listing will Change to OTCQX Marketplace from New York Stock Exchange	Nov. 22	CI
Sonendo Receives Suspension Notice From NYSE	Nov. 21	MT
Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023	Nov. 21	CI
Goldman Sachs Adjusts Sonendo's Price Target to $1.50 From $1.75, Maintains Buy Rating	Nov. 09	MT
Morgan Stanley Adjusts Price Target on Sonendo to $4.60 From $5, Maintains Equal-Weight Rating	Nov. 09	MT
Transcript : Sonendo, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (SONX) SONENDO Reports Q3 Revenue $10.4M, vs. Street Est of $10.4M	Nov. 08	MT
Sonendo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Sonendo Expects Q3 Revenue of $10.4 Million; Maintains 2023 Revenue Outlook	23-10-10	MT
Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2023	23-10-10	CI
Sonendo Signs Partnership Agreements to Expand Access to GentleWave Procedure for Root Canal Treatment	23-10-04	MT
Sonendo, Inc. Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment	23-10-04	CI

Chart Sonendo, Inc.

Duration

Period

More charts

Company Profile

Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Sonendo, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.096 USD

Average target price

0.25 USD

Spread / Average Target

+160.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SONENDO, INC.	-54.29%	6.76M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution